Zoetis ZTS

Zoetis, Inc. is an animal health company that develops, manufactures, and markets animal health medicines, vaccines, and diagnostic products. The company, which was founded in 1952, is based in Parsippany, New Jersey. Zoetis operates in the United States and internationally.

The company develops species-specific products for livestock such as cattle and sheep, pigs, poultry, fish, and companion animals that include cats, dogs, and horses. Zoetis vaccines and other biological preparations protect animals against diseases such as respiratory, gastrointestinal, and reproductive ailments. These medicines also induce immune-specific responses to counter diseases. The company's anti-infective drugs are designed to prevent, kill, or slow the growth of bacteria, fungi, protozoa, and parasiticides such as fleas, ticks, and worms. Other pharmaceutical products include pain killers and sedatives, antiemetic, reproductive, oncology, and dermatological therapeutics. Zoetis also manufactures and supplies portable blood and urine analyses systems and point-of-care diagnostic products.

Additionally, the company offers biodevices, genetic tests, and precision livestock farming services. Zoetis customers include veterinarians, livestock producers, retailers, sales representatives, and other applicable distribution channels. The company is publicly listed on the NYSE under the ZTS ticker.

Keep up to date with the ZTS share price by adding Zoetis, Inc. to your watchlist on eToro.